Clinical trial
NEMO - an App for Side Effect Management in Oncology
NCT04493450 is registered in ClinicalTrials.gov with Thomas Seufferlein as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- NEMO - an App for Side Effect Management in Oncology
- Lead sponsor
- Thomas Seufferlein
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- September 1, 2020
- Completion date
- June 30, 2022
- Enrollment
- 66 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cancer patients